ScoreComparison
Why is Human Metabolome Technologies, Inc. ?
1
Flat results in Dec 25
- NET PROFIT(HY) At JPY 25.87 MM has Grown at -62.19%
- ROCE(HY) Lowest at 11.09%
- RAW MATERIAL COST(Y) Grown by 5.6% (YoY)
2
With ROE of 14.19%, it has a very attractive valuation with a 2.30 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.41%, its profits have risen by 11.2% ; the PEG ratio of the company is 1.5
3
Underperformed the market in the last 1 year
- The stock has generated a return of 2.41% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 38.30%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Human Metabolome Technologies, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Human Metabolome Technologies, Inc.
2.41%
0.36
30.01%
Japan Nikkei 225
40.96%
1.35
28.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.86%
EBIT Growth (5y)
31.89%
EBIT to Interest (avg)
71.02
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.67
Tax Ratio
10.65%
Dividend Payout Ratio
34.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.30%
ROE (avg)
11.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
2.30
EV to EBIT
10.36
EV to EBITDA
7.95
EV to Capital Employed
5.25
EV to Sales
2.23
PEG Ratio
1.46
Dividend Yield
NA
ROCE (Latest)
50.66%
ROE (Latest)
14.19%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
NET PROFIT(HY)
At JPY 25.87 MM has Grown at -62.19%
ROCE(HY)
Lowest at 11.09%
RAW MATERIAL COST(Y)
Grown by 5.6% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at -60.98 %
Here's what is not working for Human Metabolome Technologies, Inc.
Net Profit
At JPY 25.87 MM has Grown at -62.19%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Debt-Equity Ratio
Highest at -60.98 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.6% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
